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We summarize the evolutionary relationship, structure
and subcellular distribution of SUMO proteases
(or SUMO isopeptidases). We also discuss their functions
and allude to their involvement in human disease.
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protease, SENP, Desi-1, Desi-2, USPL1termed SUMO isopeptidases or SUMO-specific proteases.
Members of this enzyme class function as deconjugatingIntroduction
The ubiquitin-like SUMO (small ubiquitin-related modi-
fier) system is a post-translational protein modification
pathway in eukaryotes [1,2]. SUMOylation is a highly dy-
namic process, where deconjugation (deSUMOylation) is
catalyzed by a family of cysteine proteases, termed
SUMO-specific proteases or SUMO isopeptidases. A
subset of these enzymes also functions in processing of
the SUMO precursor proteins, which is a prerequisite
for their conjugation. In this review, we summarize the
current view of SUMO deconjugating enzymes. We dis-
cuss their evolutionary relationships, subcellular distri-
butions and functions as well as their involvement in
human disease.
SUMO belongs to the family of ubiquitin-like proteins.
Like ubiquitin, it functions as a protein modifier that is
covalently attached to ε-amino groups of lysine residues
of target proteins [1,2]. Lower eukaryotes attach a single
SUMO form (known as smt3) to target proteins,
whereas the human SUMO system makes use of three
related SUMO forms (SUMO1, SUMO2 and SUMO3).
All SUMO/smt3 forms are expressed as precursor pro-
teins that require carboxy-terminal proteolytic process-
ing prior to their conjugation. Processing exposes a
carboxy-terminal di-glycine motif, which is essential for
conjugation. Subsequent conjugation proceeds by a
pathway that typically involves an E1-E2-E3 enzymatic* Correspondence: ste.mueller@em.uni-frankfurt.de
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protein-protein interactions by recruiting binding part-
ners that harbor specific SUMO-interaction motifs
(SIMs).
Regulated deconjugation of SUMO from its substrates is
a central element of the SUMO system as it assures the
plasticity of protein interaction networks. The deconjuga-
tion process is catalyzed by a family of cysteine proteases,
enzymes for isopeptide-linked SUMO-protein conjugates
and also depolymerize isopeptide-linked poly-SUMO2/3
chains. Moreover, some family members act as processing
factors for the carboxy-terminal maturation of the SUMO
precursor. The known SUMO-specific isopeptidases and
proteases are cysteine proteases that are classified into
three distinct families: the Ulp/SENP (ubiquitin-like prote-
ase/sentrin-specific protease) family, the Desi (deSUMOy-
lating isopeptidase) family and USPL1 (ubiquitin-specific
peptidase-like protein 1).Gene organization and evolutionary history
All identified SUMO isopeptidases/proteases are cyst-
eine proteases. They share a similar catalytic mechanism
but belong to different superfamilies that are distin-
guished by the fold of their respective catalytic domains.
Ulp/SENP proteins belong to the C48 family subgroup
of the CE superfamily of thiol proteases whose founder
member is Ulp1, first discovered in the yeast Saccharo-
myces cerevisiae [3]. Subsequently, Ulp2 was identified
as a second SUMO-deconjugating enzyme in yeast [4].
Ulp1/2-related isopeptidase genes are also found in the
genome of Drosophila melanogaster [5,6]. In higher eu-
karyotes, the family is more diverse. Seven human pro-
teins were initially classified as Ulp family members and
annotated as SENPs [7]. (The term sentrin was coined
by Ed Yeh as an alternative name for SUMOs.) Notably,
however, later experimental work revealed that SENP8
acts on the ubiquitin-family member Nedd8, but not on
SUMO paralogs [8,9]. The human genome thereforentral Ltd. The licensee has exclusive rights to distribute this article, in any
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Figure 2 Structural organization of SUMO-specific-proteases/
isopeptidases. The domain organizations of Ulp/SENPs and Desi
family members are shown. Green ovals represent the catalytic
domain. The sequence determinants that are responsible for
subcellular targeting are represented by orange ovals. The length of
the proteins as total number of amino acids is presented on the
right side. For the catalytic domains of SENP family members,
sequence identity shared with SENP1 is also shown.
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Ulp/SENP family: SENP1, SENP2, SENP3, SENP5,
SENP6 and SENP7. Sequence analyses and phylogenetic
comparison of the human SENPs with Ulp1 and Ulp2
from lower eukaryotes illustrate that SENP1, SENP2,
SENP3 and SENP5 are evolutionarily related to the Ulp1
branch, whereas SENP6 and SENP7 are related to the
Ulp2 branch (Figure 1). The tree further reveals the pair-
wise similarity of SENP1 to SENP2, SENP3 to SENP5
and SENP6 to SENP7.
The deSUMOylating isopeptidases Desi-1 and Desi-2
belong to the evolutionarily distinct C97 family of cyst-
eine proteases [10]. Orthologs of Desi-1 and Desi-2 are
found in plants and metazoa, but are missing in lower
eukaryotes such as yeast.
USPL1 is, to date, the only known mammalian
SUMO-specific protease of the C98 family [11]. USPL1-
related deconjugases are found in metazoan vertebrates
and invertebrates. USPL1 is not related to the Ulp/SENP
and Desi families, but the catalytic domain of USPL1
shows homology to the C19 family of ubiquitin-specific
proteases. For example, within this region, USPL1 shares
around 20% sequence identity with the ubiquitin-
deconjugating enzyme USP1.Characteristic structural features
The common characteristic of the Ulp/SENP family is
their conserved catalytic domain, which spans around
200 amino acids in the carboxy-terminal part of the pro-
tein (Figure 2). This domain has sequence and structural
similarity to the catalytic region of adenoviral proteases,
which cleave viral and cellular proteins. The human
Ulp/SENP family members share 20 to 60% sequence
















Figure 1 Evolutionary relationship of Ulp/SENP family
members. The phylogenetic tree displays the relationship between
Saccharomyces cerevisiae (S.c.), Drosophila melanogaster (Dm) and
human Ulp/SENP family members. Confidence numbers generated
by the bootstrapping procedure are shown for each branch in the
tree. The following sequences were used for input: SENP1 UniProtKB,
Q9P0U3; SENP2 UniProtKB, Q9HC62; SENP3 UniProtKB, Q9H4L4;
SENP5 UniProtKB, Q96HI0; SENP6 UniProtKB, Q9GZR1; SENP7
UniProtKB, Q9BQF6; Dm_ULP1, GenBank AAF48933.1; Dm_ULP2
(Velo; verloren), GenBank AAS65070.1; S.c._ULP1, UniProtKB/Swiss-
Prot Q02724.1; S.c._ULP2, UniProtKB/Swiss-Prot P40537.SENP2, SENP3-SENP5 and SENP6-SENP7 pairs show
the highest degree of similarity to each other. SENP6
and SENP7 are most divergent from the rest of the
family and harbor conserved sequence insertions within
their catalytic domains. Structural data describing the
catalytic domain of yeast Ulp1 and human SENP1 and
SENP2 in complex with SUMO precursors or
isopeptide-linked SUMO-RanGAP1 conjugates revealed
important insights into the catalytic features of this en-
zyme class [12-16]. The active site cysteine residue is
embedded in a typical catalytic triad (Cys-His-Asp). An
additional invariant Gln residue in close proximity stabi-
lizes the transition state during catalysis. The substrate
accesses the catalytic site through a shallow tunnel, in
which conserved Trp residues are essential for position-
ing the di-glycine motif and the scissile bond over the
active site. A remarkable finding was that the scissile
bond of the pre-SUMO variants or a SUMO-conjugate
is oriented in a cis configuration for cleavage [14,15].
In addition to their conserved catalytic domain, all
SENPs have amino-terminal regions of variable length
that have crucial regulatory functions. These regions fre-
quently contain interaction domains for cellular adaptor
proteins that determine the subcellular distribution of
Ulp/SENP family members [17-19]. Post-translational
modifications, such as phosphorylation or ubiquitylation,
within these regions provide additional regulatory layers
for the recruitment of binding partners or the control of
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contain one or more SIM modules in their amino-
terminal region, which probably contribute to the selec-
tion of substrates or facilitate the targeting of specific
SENPs to poly-SUMO chains.
Desi-1 and Desi-2 are small proteins characterized by
PPPDE (permutated papain fold peptidases of the
double-stranded RNA viruses and eukaryotes) domains
of around 140 amino acids. Desi-1 and Desi-2 share
about 20% sequence identity within this region. Struc-
tural data from Desi-1 revealed that the protein forms a
homodimer, in which the groove between the two
subunits forms the active site. This region contains two
conserved cysteine and histidine residues that form a
catalytic dyad [10,24]. Interestingly, the active-site
groove of Desi-1 is occupied by its own carboxy-
terminal segment [24], which is very different from the
open cleft in SENPs.
The catalytic domain of USPL1 contains a catalytic
triad composed of Cys-His-Asp-residues [11,25].
Localization
The different SUMO isopeptidases have characteristic
subcellular distributions, which seems to be a way of
restricting their activity to a specific set of substrates. The
Ulp/SENP family members are predominantly concen-
trated in distinct subnuclear regions (Figure 3). SENP1
and SENP2, as well as the yeast Ulp1 enzyme, are concen-
trated at the nuclear envelope through their interaction
with components of the nuclear pore complex [18,26-28].
Within the nucleus SENP1 and SENP2 are excluded from








Figure 3 Schematic representation of the subcellular distribution of m
families. The predominant subcellular distribution of the respective SENPs
envelope; No, nucleolus; PML, promyelocytic leukemia nuclear bodies.overlap with PML nuclear bodies. In mitosis, SENP1 and
SENP2 redistribute from the nuclear envelope to the kin-
etochore [29]. It is worth noting that despite its predomin-
ately nuclear localization, SENP2 was reported to shuttle
between the nucleus and the cytoplasm [30]. Moreover,
distinct splice variants of SENP2 may exhibit specific sub-
cellular distributions [31].
SENP3 and SENP5 are compartmentalized in the nu-
cleolus, where they act on proteins that are involved in
the early steps of ribosome maturation [17,32-34]. A
subfraction of SENP3 and SENP5 also resides in the nu-
cleoplasm and the cytoplasm. Interestingly, at G2/M
transition, prior to nuclear envelope breakdown, SENP5
translocates to the mitochondrial surface [35]. SENP6
and SENP7 mainly exhibit a nucleoplasmic distribution.
In contrast to SENPs, Desi family members are primarily
concentrated in the cytoplasm [35]. USPL1 is a predom-
inantly nuclear protein and co-localizes with coilin in
Cajal bodies [11,25].
Function
SUMO maturation versus SUMO deconjugation
Ulp/SENPs can act as deconjugating or maturation/pro-
cessing enzymes. The yeast Ulp family was covered in a
recent review [31] and will not be further discussed here.
Distinct human SENPs exert different activities in either
processing or deconjugation (Figure 4). Moreover, pref-
erences for specific SUMO paralogs have been reported
for specific SENPs as outlined below. The maturation
process removes the amino acids carboxy-terminal to a
di-glycine motif, whose exposure is essential for conjuga-
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Figure 4 SUMO processing and SUMO deconjugation activities
of human SENP family members. Schematic representation of
SENP processing and deconjugation activities towards distinct SUMO
paralogs. The left part summarizes the activities of SENPs in
maturation/processing of human SUMO paralogs. The maturation
process removes the amino acids carboxy-terminal to a di-glycine
(GG) motif (sequences are given for the human SUMO variants).
The middle part describes the specificity for deconjugating distinct
SUMO forms from substrates (isopeptidase activity). The right part
highlights the activity of SENP6 and SENP7 for editing lysine
(K)-linked SUMO2/3 chains. These chains are predominantly formed
by SUMO2 and SUMO3 and are preferentially linked via K11. The
figure tries to integrate data from biochemical in vitro experiments
and cell-based assays.
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terminal to the di-glycine motif.
Biochemical experiments have established a role for
SENP1 in both SUMO deconjugation and SUMO process-
ing. The data show that SUMO-1 is processed most effi-
ciently, followed by SUMO-2 and SUMO-3. By contrast, at
least in vitro, SENP1 displayed little specificity in its ability
to deconjugate the different SUMO paralogs from SUMO-
modified substrates [13,15,16]. Recent genetic data from
mice, however, suggest that in vivo SENP1 has only a limited
role in SUMO-2 and SUMO-3 deconjugation, but is essen-
tial for deSUMOylating SUMO1-modified proteins [36].
Biochemical experiments demonstrate that SENP2 catalyzes
SUMO deconjugation more efficiently than SUMO process-
ing and is most efficient for SUMO2 over SUMO1 and
SUMO3 [14,37,38]. The SENP3-SENP5 couple shows a very
strong preference for processing and deconjugation of
SUMO2 and SUMO3 and does not exhibit significant pro-
cessing and deconjugase activity for SUMO1 [32,39]. SENP6
and SENP7 exert only very weak processing activity and are
also rather inefficient in deconjugating monomeric SUMO
from substrates. Importantly, however, SENP6 and SENP7,
as well as the related Ulp2 from yeast, are excellent enzymes
for deconjugating SUMO moieties from SUMO2-SUMO3
di-SUMOylated substrates and from polymeric chains of
SUMO2 and SUMO3 [39-42]. Their main function seems
to be the editing of lysine-linked SUMO-SUMO chains.In contrast to Ulp/SENP family members, the Desi-1 and
Desi-2 enzymes exert isopeptidase activity on a selected
substrate, but have only an extremely low processing activity
for the pre-SUMO precursor protein [10,24]. USPL1 is
active in processing and deconjugation.
Substrate specificity of SUMO proteases
With only nine SUMO isopeptidases identified to date,
the SUMO-deconjugating machinery appears to be less
complex than the de-ubiquitylating system. Even if there
are unidentified SUMO isopeptidases or additional alter-
native splice variants of SENPs, their total number is
likely to remain far below the currently known 100 ubi-
quitin deconjugases. The situation is similar when com-
paring the number of E3 ubiquitin ligases and E3 SUMO
ligases. Why the modification and demodification of
hundreds of different SUMO conjugates are controlled
by only a limiting set of enzymes is a central question in
the field. One scenario is that the SUMO system, includ-
ing the deconjugation machinery, coordinately regulates
groups of proteins that are functionally and physically
linked [43]. In this scenario, a given SUMO isopeptidase
is likely to act on a larger set of proteins, which in many
cases are associated in larger protein complexes. For
example, the human SENP3 enzyme deconjugates a
number of SUMO2/3 conjugates at nucleolar pre-60S
ribosomes [33,34,44-47]. The concept of group modifica-
tion or demodification complicates the interpretation of
experimental approaches that had concentrated on indi-
vidual SUMO substrates for a given isopeptidase. In the
following, we will try to integrate the available data to
provide a more general picture and to define cellular
pathways that are controlled by a distinct SUMO
isopeptidase.
Cellular pathways regulated by SUMO-specific
isopeptidases
SENP1
The inactivation of transcription factors by SUMO con-
jugation and their activation by SUMO deconjugation is
a recurrent theme. SENP1-mediated deSUMOylation
seems to be crucial for the activation of transcriptional
programs in innate immune responses and in the devel-
opment of B and T cells. In these processes, IRF8,
STAT5 and Bcl11b have been defined as relevant SENP1
targets [48-50], but SENP1 probably acts on a broader
spectrum of transcription factors in these pathways and
other processes. Along this line, it has been shown that
deSUMOylation of HIF1α by SENP1 under conditions of
hypoxia is required for stabilization of HIF1α and the
expression of HIF1α target genes. Recruitment of SENP1
to specific substrates could be coordinated by post-
translational modifications as exemplified by the
phospho-dependent binding of SENP1 to Bcl11b [50].
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strates at the kinetochore. This is critical for mitotic pro-
gression because the knockdown of SENP1 delays sister
chromatid separation at metaphase [29].SENP2
Like SENP1, SENP2 is involved in the regulation of gene
expression programs in developmental processes. Yeh and
co-workers [51] demonstrated that deletion of the SENP2
gene in mice causes defects in cardiac development result-
ing from the reduced expression of Gata4 and Gata6. This
reduced expression has been linked to the lack of SENP2-
mediated deSUMOylation of a subunit of the polycomb
repressive complex 1 (PRC1). PRC1 represses transcrip-
tion of Gata4, Gata6 and numerous other developmental
regulator genes, indicating a central role for SENP2 in
early embryonic development.SENP3
SENP3 has a well-established function in the control of
ribosome biogenesis and particularly affects the matur-
ation of the 28S rRNA [33,34]. This is likely to involve
the SENP3-catalyzed removal of SUMO2 or SUMO3
from various 60S maturation factors acting on nucleolar
pre-60S ribosomal particles. In addition to its role in
ribosome biogenesis, a nucleoplasmic subfraction of
SENP3 controls transcriptional processes through demo-
dification of transcriptional co-regulators and compo-
nents of chromatin-modifying complexes [52]. Recent
data show that SENP3-mediated deSUMOylation con-
trols the expression of osteogenic differentiation factors
and of other developmental regulators through deSU-
MOylation of MLL1/2 histone-methyltransferase com-
plexes [53].
SENP3 abundance and subcellular distribution are
tightly regulated by environmental stimuli. Redox-
sensitive cysteine residues in the amino-terminal region
trigger the stabilization of SENP3 in response to redox
stress, whereas the PERK1 kinase pathway induces its
lysosomal degradation in response to oxygen or glucose
deprivation [20,54]. In mitosis, SENP3 is heavily phos-
phorylated, which may control its substrate specificity
and/or subcellular distribution [21].SENP5
The nucleolar function of SENP5 is also related to the
ribosome biogenesis pathway, where it is involved in
RNA polymerase I-mediated transcription of the 47S
rRNA [34]. As mentioned above, upon G2/M transition,
SENP5 translocates to mitochondria, where the deSU-
MOylation of mitochondrial proteins seems to drive
mitochondrial fragmentation during mitosis [35,55].SENP6
SENP6 is the principal chain-editing enzyme in human cells
and accordingly regulates multiple signaling pathways that
are controlled by poly-SUMOylation. A well-characterized
poly-SUMO2/3-regulated process is SUMO-mediated ubi-
quitylation by SUMO-targeted ubiquitin-ligases (StUbLs).
StUBLs, whose prototypic member is RNF4, are poly-
SUMO2/3-binding ubiquitin ligases that are recruited to
poly-SUMOylated substrates to trigger their ubiquitylation.
Among the established targets of RNF4 are the promye-
locytic leukemia (PML) protein and the inner kineto-
chore protein CENP-I. SENP6 counterbalances this
poly-SUMO-RNF4-dependent degradation pathway by
preventing the polySUMOylation of PML or CENP-I, as
evidenced by the accumulation of both proteins in the
absence of SENP6 [56-58]. Other defined substrates for
SENP6 are the NF-κB regulator NEMO and the replica-
tion factor RPA70 [59,60]. How SENP6 is selectively
targeted to its substrates under specific conditions is
currently not understood.
SENP7
Similar to SENP6, SENP7 preferentially acts on SUMO-
SUMO chains. Small interfering RNA (siRNA)-mediated
SENP7 depletion experiments point to the crucial involve-
ment of SENP7 in chromatin remodeling and chromatin dy-
namics. It has been proposed that chromatin relaxation in
response to DNA damage is promoted by SENP7-mediated
removal of SUMO2/3 chains from the KRAB-associated
protein 1 (KAP1) [19]. This allows the recruitment of the
chromatin remodeler CHD3, which triggers chromatin re-
laxation. Importantly, the heterochromatin protein HP1
seems to function as the chromatin-targeting adaptor for
SENP7 and may itself be a substrate for SENP7. Interest-
ingly, recent work identified a shorter splice variant of
SENP7, which lacks the HP1 binding domain and accord-
ingly is unable to deSUMOylate HP1 [61]. These data exem-
plify the possible role of alternative splicing of SENPs for
substrate selection.
Desi-1/2 and USPL1
Only limited functional data on Desi-1/2 and USPL1 are
currently available. Desi-1 and -2 seem to have a more re-
stricted substrate specificity, with the transcriptional repres-
sor BZEL being the only substrate identified to date [10].
Consistent with its localization to Cajal bodies, USPL1 has
been shown to be important for small nuclear ribonucleic
particle (snRNP) assembly and pre-mRNA splicing, but the
relevant substrates have not yet been identified [11,25].
Frontiers
Among the most burning questions in the field is the
target specificity of distinct SUMO isopeptidases. Quan-
titative mass-spectrometry approaches that monitor
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members are depleted might be one promising approach
to answer this question. Unraveling the substrate specifi-
city of distinct SENP splice variants would also be an
important aspect along this line. Considering that
USPL1 exerts essential non-catalytic functions [11], it is
also crucial to define potential functions of other SUMO
isopeptidases that are not linked to their catalytic activ-
ity. Knock-in mice expressing catalytic-dead variants of
the respective enzymes would be the best model system
to tackle this search.
Future work will also need to uncover how the misre-
gulation of SENPs is linked to human disease. Most
studies have focused on an involvement of SENPs in the
development and/or progression of cancer [62]. Overex-
pression of SENP1 has been correlated with prostate
cancer aggressiveness and metastatic potential [63-65].
This is at least partially mediated through induction of
HIF1α-dependent signaling pathways. SENP1 addition-
ally activates other oncogenic signaling pathways, such
as c-Jun and androgen-receptor-mediated transcription.
Like SENP1, SENP3 accumulates in several human can-
cers, with colon carcinomas having the highest ratio of
SENP3 expression [54,66]. These and other data indicate
a potential significance for SENPs as diagnostic markers
and also make this enzyme class an attractive drug target
in distinct human tumors [67,68].
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